Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
Guardado en:
Autores principales: | Lisha Du, Zikang Xing, Bangbao Tao, Tianqi Li, Dan Yang, Weirui Li, Yuanting Zheng, Chunxiang Kuang, Qing Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9fe96d728c641a4979666fa13d7f184 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
por: Yuying Liu, et al.
Publicado: (2017) -
AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle
por: Young-Chae Kim, et al.
Publicado: (2018) -
DEHP mediates drug resistance by directly targeting AhR in human breast cancer
por: Tsung-Hua Hsieh, et al.
Publicado: (2022) -
Endogenous regulation of the Akt pathway by the aryl hydrocarbon receptor (AhR) in lung fibroblasts
por: Fangyi Shi, et al.
Publicado: (2021) -
Serotonin is an endogenous regulator of intestinal CYP1A1 via AhR
por: Christopher Manzella, et al.
Publicado: (2018)